3
34
Growth Score
-7 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.
- Omri Amirav-Drory: Venture PartnerPast Role: Genome Compiler, Founder & CEO
Emily Leproust: Investment CommitteePast Role: Agilent Technologies, Director of Applications & Chemistry R&D—Genomics
About the Company
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.
Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massive
implications.
